These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 28548247)

  • 1. Market for Artemether-Lumefantrine to treat childhood malaria in a district of southern Mozambique.
    Alonso S; Munguambe K; Sicuri E
    Health Econ; 2017 Dec; 26(12):e345-e360. PubMed ID: 28548247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization and evaluation of lipid emulsions for intravenous co-delivery of artemether and lumefantrine in severe malaria treatment.
    Yang Y; Gao H; Zhou S; Kuang X; Wang Z; Liu H; Sun J
    Drug Deliv Transl Res; 2018 Oct; 8(5):1171-1179. PubMed ID: 29748832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a paediatric physiologically based pharmacokinetic model to assess the impact of drug-drug interactions in tuberculosis co-infected malaria subjects: A case study with artemether-lumefantrine and the CYP3A4-inducer rifampicin.
    Olafuyi O; Coleman M; Badhan RKS
    Eur J Pharm Sci; 2017 Aug; 106():20-33. PubMed ID: 28546104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malaria case management commodity supply and use by community health workers in Mozambique, 2017.
    Davlantes E; Salomao C; Wate F; Sarmento D; Rodrigues H; Halsey ES; Lewis L; Candrinho B; Zulliger R
    Malar J; 2019 Feb; 18(1):47. PubMed ID: 30791915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and in vitro/in vivo evaluation of artemether and lumefantrine co-loaded nanoliposomes for parenteral delivery.
    Shakeel K; Raisuddin S; Ali S; Imam SS; Rahman MA; Jain GK; Ahmad FJ
    J Liposome Res; 2019 Mar; 29(1):35-43. PubMed ID: 29179636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
    Tshefu AK; Gaye O; Kayentao K; Thompson R; Bhatt KM; Sesay SS; Bustos DG; Tjitra E; Bedu-Addo G; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L;
    Lancet; 2010 Apr; 375(9724):1457-67. PubMed ID: 20417857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in willingness to pay for artemisinin-based combinations or monotherapy: experiences from the United Republic of Tanzania.
    Wiseman V; Onwujekwe O; Matovu F; Mutabingwa TK; Whitty CJ
    Bull World Health Organ; 2005 Nov; 83(11):845-52. PubMed ID: 16302041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artemether + lumefantrine: new drug. An alternative to atovaquone + proguanil.
    Prescrire Int; 2008 Apr; 17(94):54-6. PubMed ID: 18516806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of introducing subsidized combination treatment with artemether-lumefantrine on sales of anti-malarial monotherapies: a survey of private sector pharmacies in Huambo, Angola.
    Lussiana C; Floridia M; Martinho do Rosário J; Fortes F; Allan R
    Trans R Soc Trop Med Hyg; 2016 Dec; 110(10):588-596. PubMed ID: 27856948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Care-seeking behaviour and treatment practices for malaria in children under 5 years in Mozambique: a secondary analysis of 2011 DHS and 2015 IMASIDA datasets.
    Cassy A; Saifodine A; Candrinho B; Martins MDR; da Cunha S; Pereira FM; Samo Gudo E
    Malar J; 2019 Apr; 18(1):115. PubMed ID: 30940127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Artesunate-Amodiaquine on Mortality Related to Ebola Virus Disease.
    Gignoux E; Azman AS; de Smet M; Azuma P; Massaquoi M; Job D; Tiffany A; Petrucci R; Sterk E; Potet J; Suzuki M; Kurth A; Cannas A; Bocquin A; Strecker T; Logue C; Pottage T; Yue C; Cabrol JC; Serafini M; Ciglenecki I
    N Engl J Med; 2016 Jan; 374(1):23-32. PubMed ID: 26735991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial.
    Roth JM; Sawa P; Makio N; Omweri G; Osoti V; Okach S; Choy F; Schallig HDFH; Mens P
    Malar J; 2018 May; 17(1):199. PubMed ID: 29764419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.
    Zongo I; Dorsey G; Rouamba N; Tinto H; Dokomajilar C; Guiguemde RT; Rosenthal PJ; Ouedraogo JB
    Lancet; 2007 Feb; 369(9560):491-8. PubMed ID: 17292769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deploying artemether-lumefantrine with rapid testing in Ethiopian communities: impact on malaria morbidity, mortality and healthcare resources.
    Lemma H; Byass P; Desta A; Bosman A; Costanzo G; Toma L; Fottrell E; Marrast AC; Ambachew Y; Getachew A; Mulure N; Morrone A; Bianchi A; Barnabas GA
    Trop Med Int Health; 2010 Feb; 15(2):241-50. PubMed ID: 19961564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The malaria testing and treatment landscape in the southern Lao People's Democratic Republic (PDR).
    ; Phanalasy S
    Malar J; 2017 Apr; 16(1):169. PubMed ID: 28438155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot Study of the Addition of Mass Treatment for Malaria to Existing School-Based Programs to Treat Neglected Tropical Diseases.
    Cohee LM; Chilombe M; Ngwira A; Jemu SK; Mathanga DP; Laufer MK
    Am J Trop Med Hyg; 2018 Jan; 98(1):95-99. PubMed ID: 29141763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A randomized clinical trial comparing the effectiveness and tolerability of artemisinine-naphthoquine (Arco®) and artemether-lumefantrine (Coartem®) in the treatment of uncomplicated malaria in Benin].
    Kinde-Gazard D; Ogouyèmi-Hounto A; Capo-Chichi L; Gbaguidi J; Massougbodji A
    Bull Soc Pathol Exot; 2012 Aug; 105(3):208-14. PubMed ID: 22328063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial.
    Piola P; Fogg C; Bajunirwe F; Biraro S; Grandesso F; Ruzagira E; Babigumira J; Kigozi I; Kiguli J; Kyomuhendo J; Ferradini L; Taylor W; Checchi F; Guthmann JP
    Lancet; 2005 Apr 23-29; 365(9469):1467-73. PubMed ID: 15850630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria case-management under artemether-lumefantrine treatment policy in Uganda.
    Zurovac D; Tibenderana JK; Nankabirwa J; Ssekitooleko J; Njogu JN; Rwakimari JB; Meek S; Talisuna A; Snow RW
    Malar J; 2008 Sep; 7():181. PubMed ID: 18803833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case-control auditory evaluation of patients treated with artemether-lumefantrine.
    Hutagalung R; Htoo H; Nwee P; Arunkamomkiri J; Zwang J; Carrara VI; Ashley E; Singhasivanon P; White NJ; Nosten F
    Am J Trop Med Hyg; 2006 Feb; 74(2):211-4. PubMed ID: 16474072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.